ArticleScientific reports2018

Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer.

W Y Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.